Results 131 to 140 of about 62,685 (235)

Pseudoprogression During Enfortumab Vedotin Plus Pembrolizumab Therapy in Muscle‐Invasive Bladder Cancer Achieving Pathological Complete Response: A Case Report

IJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Enfortumab vedotin plus pembrolizumab has emerged as a standard first‐line therapy for advanced urothelial carcinoma (UC). However, pseudoprogression during this combination remains poorly characterized. Case Presentation A 71‐year‐old man with muscle‐invasive bladder cancer and lymph node metastasis received enfortumab vedotin ...
Yosuke Nakanishi, Yohei Kawashima, Masanao Shinohara, Kazuhisa Hagiwara, Kohei Inui, Kazue Ogawa, Daiji Fujimori, Shingo Moriyama, Hanako Oba, Sato Satoshi   +9 more
wiley   +1 more source

Urothelial carcinoma with trophoblastic differentiation: case report and review of literature. [PDF]

Med Pharm Rep
Tichil BP, Inisca P, Gheju A, Fetica B, Besleaga A, Vica ML, Florea A.   +6 more
europepmc   +1 more source

Metastatic Urachal Carcinoma With Microsatellite Stability and Low Tumor Mutational Burden Achieving a Durable Response to Pembrolizumab After Platinum Failure

IJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Urachal carcinoma is a rare and aggressive malignancy with no established systemic therapy after platinum failure. Evidence for immune checkpoint inhibitors (ICIs) remains limited, particularly in tumors without established favorable biomarkers such as microsatellite instability‐high status or high tumor mutational burden.
Fumihiro Ito, Koki Kobayashi, Gaku Hayashi, Shunsuke Kamijo, Takashi Fujita   +4 more
wiley   +1 more source

Inflammatory Pseudotumour in Common Seal (Phoca vitulina): A Case Report

Veterinary Medicine and Science, Volume 12, Issue 6, November 2026.
A 19‐year‐old intact male common seal (Phoca vitulina) diagnosed with a chronic ulcer. Microbiology identified Vibrio alginolyticus. Radiography noted phalanx alterations. Macroscopic, histopathological, and immunohistochemical examinations revealed a neoplastic origin with a myofibroblastic phenotype. This report describes the first documented case of
Javier M. De Pablo‐Moreno, Rocío Canales, Mireia Mainez, Nicolás Aradilla, Blanca Chinchilla, Néstor Porras, Ignacio Vargas‐Castro, Antonio Rodríguez‐Bertos   +7 more
wiley   +1 more source

Lynch syndrome-associated urothelial carcinoma: clinical and molecular findings from a single-institution cohort. [PDF]

Fam Cancer
Rametta A, Barella M, Scardino A, Barbetta F, Tamborini E, Perrone F, Busico A, Agnelli L, Rota S, Gusmaroli E, Stellato M, Nuzzo A, Guadalupi V, Claps M, Ricci MT, Procopio G, Pruneri G, Milione M, Giannatempo P, Vitellaro M.   +19 more
europepmc   +1 more source

Indirect Comparison of Neoadjuvant Treatment Strategies for Muscle‐Invasive Bladder Cancer: ddMVAC and Perioperative Durvalumab‐Gemcitabine‐Cisplatin Versus Gemcitabine‐Cisplatin: A Systematic Review and Network Meta‐Analysis of Randomised Controlled Trials

International Journal of Cancer, Volume 159, Issue 8, Page 1962-1973, 15 October 2026.
Optimizing neoadjuvant therapy for muscle‐invasive bladder cancer patients who are eligible for cisplatin remains difficult, owing particularly to high toxicity and recurrence rates. This meta‐analysis compared dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) against durvalumab plus gemcitabine‐cisplatin (D‐GC) and GC alone ...
Maurin Helen Mangold, Gloria Baumann, Victoria Luise Simone Wieland, Nicolas Carl, Luisa Vivienne Renner, Alexander Studier‐Fischer, Hanna Menold, Stefanie Zschäbitz, Frederik Wessels, Niklas Westhoff, Maurice Stephan Michel, Karl‐Friedrich Kowalewski, Caelán Max Haney‐Aubert   +12 more
wiley   +1 more source

Real-World Outcomes of Second-Line Chemotherapy in Metastatic Urothelial Carcinoma. [PDF]

Curr Oncol
Çıtakkul İ, Arvas H, Karaoğlan M, Köylü B, Demir N, Balkaya Aykut G, Şahin E, Yılmaz M, Urakçı Z, Bayır Garbioğlu D, Selçukbiricik F, Baydar E, Tazebay BN, Yazıcı M, Bakkal Temi Y, Çabuk D, Uygun K, Kefeli U.   +17 more
europepmc   +1 more source

Klippel–Trénaunay Syndrome With Pelvic/Rectal and Urinary Bladder Involvement: A Rare Case Report

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Concurrent bladder and rectosigmoid vascular malformations in Klippel–Trénaunay syndrome can mimic synchronous pelvic malignancy. Multidisciplinary clinical, radiological, endoscopic, and pathological evaluation is essential to avoid misdiagnosis and to guide appropriate, often conservative, management.
Somaya Al Kiswani, Khitam Salahat, Omar Daas, Mohammed AbdulJabbar Abed, Reem Abuhamdah, Usama Al Khuffash, Abdullah Nofal   +6 more
wiley   +1 more source

Disease stage-dependent expression of ADC-related biomarkers in urothelial carcinoma. [PDF]

Transl Androl Urol
Rausch S, Bombyk A, Müller L, Hennenlotter J, Maas M, Walz S, Tsaur I, Bahlinger V, Stühler V.   +8 more
europepmc   +1 more source

Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck

Cancer Cytopathology, Volume 134, Issue 10, October 2026.
Abstract Background This study aimed to evaluate Bladder EpiCheck (BE) performance in detecting urothelial carcinoma (UC) and HG (high‐grade) events in patients with indeterminate cytology and negative cystoscopy. Methods This prospective study included 63 patients who presented with indeterminate urinary cytology and negative cystoscopy between ...
Claudia Mercader, Mercedes Ingelmo‐Torres, Fiorella L. Roldán, Marcel Figueras, Eric Villalba, Pilar Galve, Ignacio Asiaín, Meritxell Costa, Antoni Vilaseca, Josep Oriola, Agustín Franco, Antonio Alcaraz, Lourdes Mengual   +12 more
wiley   +1 more source